<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1989-07-01" modified="2020-10-07" version="204">
<accession>P05549</accession>
<accession>Q13777</accession>
<accession>Q5TAV5</accession>
<accession>Q8N1C6</accession>
<name>AP2A_HUMAN</name>
<protein>
<recommendedName>
<fullName>Transcription factor AP-2-alpha</fullName>
<shortName>AP2-alpha</shortName>
</recommendedName>
<alternativeName>
<fullName>AP-2 transcription factor</fullName>
</alternativeName>
<alternativeName>
<fullName>Activating enhancer-binding protein 2-alpha</fullName>
</alternativeName>
<alternativeName>
<fullName>Activator protein 2</fullName>
<shortName>AP-2</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">TFAP2A</name>
<name type="synonym">AP2TF</name>
<name type="synonym">TFAP2</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1988" name="Genes Dev." volume="2" first="1557" last="1569">
<title>Cloning and expression of AP-2, a cell-type-specific transcription factor that activates inducible enhancer elements.</title>
<authorList>
<person name="Williams T."/>
<person name="Admon A."/>
<person name="Luescher B."/>
<person name="Tjian R."/>
</authorList>
<dbReference type="PubMed" id="3063603"/>
<dbReference type="DOI" id="10.1101/gad.2.12a.1557"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>PARTIAL PROTEIN SEQUENCE</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1993" name="Mol. Cell. Biol." volume="13" first="4174" last="4185">
<title>An alternatively spliced mRNA from the AP-2 gene encodes a negative regulator of transcriptional activation by AP-2.</title>
<authorList>
<person name="Buettner R."/>
<person name="Kannan P."/>
<person name="Imhof A."/>
<person name="Bauer R."/>
<person name="Yim S.O."/>
<person name="Glockshuber R."/>
<person name="Van Dyke M.W."/>
<person name="Tainsky M.A."/>
</authorList>
<dbReference type="PubMed" id="8321221"/>
<dbReference type="DOI" id="10.1128/mcb.13.7.4174"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 4)</scope>
<source>
<tissue>Teratocarcinoma</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1994" name="Nucleic Acids Res." volume="22" first="1413" last="1420">
<title>The genomic structure of the human AP-2 transcription factor.</title>
<authorList>
<person name="Bauer R."/>
<person name="Imhof A."/>
<person name="Pscherer A."/>
<person name="Kopp H."/>
<person name="Moser M."/>
<person name="Seegers S."/>
<person name="Kerscher M."/>
<person name="Tainsky M.A."/>
<person name="Hofstaedter F."/>
<person name="Buettner R."/>
</authorList>
<dbReference type="PubMed" id="8190633"/>
<dbReference type="DOI" id="10.1093/nar/22.8.1413"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2003" name="Nature" volume="425" first="805" last="811">
<title>The DNA sequence and analysis of human chromosome 6.</title>
<authorList>
<person name="Mungall A.J."/>
<person name="Palmer S.A."/>
<person name="Sims S.K."/>
<person name="Edwards C.A."/>
<person name="Ashurst J.L."/>
<person name="Wilming L."/>
<person name="Jones M.C."/>
<person name="Horton R."/>
<person name="Hunt S.E."/>
<person name="Scott C.E."/>
<person name="Gilbert J.G.R."/>
<person name="Clamp M.E."/>
<person name="Bethel G."/>
<person name="Milne S."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ambrose K.D."/>
<person name="Andrews T.D."/>
<person name="Ashwell R.I.S."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Banerjee R."/>
<person name="Barker D.J."/>
<person name="Barlow K.F."/>
<person name="Bates K."/>
<person name="Beare D.M."/>
<person name="Beasley H."/>
<person name="Beasley O."/>
<person name="Bird C.P."/>
<person name="Blakey S.E."/>
<person name="Bray-Allen S."/>
<person name="Brook J."/>
<person name="Brown A.J."/>
<person name="Brown J.Y."/>
<person name="Burford D.C."/>
<person name="Burrill W."/>
<person name="Burton J."/>
<person name="Carder C."/>
<person name="Carter N.P."/>
<person name="Chapman J.C."/>
<person name="Clark S.Y."/>
<person name="Clark G."/>
<person name="Clee C.M."/>
<person name="Clegg S."/>
<person name="Cobley V."/>
<person name="Collier R.E."/>
<person name="Collins J.E."/>
<person name="Colman L.K."/>
<person name="Corby N.R."/>
<person name="Coville G.J."/>
<person name="Culley K.M."/>
<person name="Dhami P."/>
<person name="Davies J."/>
<person name="Dunn M."/>
<person name="Earthrowl M.E."/>
<person name="Ellington A.E."/>
<person name="Evans K.A."/>
<person name="Faulkner L."/>
<person name="Francis M.D."/>
<person name="Frankish A."/>
<person name="Frankland J."/>
<person name="French L."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Ghori M.J."/>
<person name="Gilby L.M."/>
<person name="Gillson C.J."/>
<person name="Glithero R.J."/>
<person name="Grafham D.V."/>
<person name="Grant M."/>
<person name="Gribble S."/>
<person name="Griffiths C."/>
<person name="Griffiths M.N.D."/>
<person name="Hall R."/>
<person name="Halls K.S."/>
<person name="Hammond S."/>
<person name="Harley J.L."/>
<person name="Hart E.A."/>
<person name="Heath P.D."/>
<person name="Heathcott R."/>
<person name="Holmes S.J."/>
<person name="Howden P.J."/>
<person name="Howe K.L."/>
<person name="Howell G.R."/>
<person name="Huckle E."/>
<person name="Humphray S.J."/>
<person name="Humphries M.D."/>
<person name="Hunt A.R."/>
<person name="Johnson C.M."/>
<person name="Joy A.A."/>
<person name="Kay M."/>
<person name="Keenan S.J."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Laird G.K."/>
<person name="Langford C."/>
<person name="Lawlor S."/>
<person name="Leongamornlert D.A."/>
<person name="Leversha M."/>
<person name="Lloyd C.R."/>
<person name="Lloyd D.M."/>
<person name="Loveland J.E."/>
<person name="Lovell J."/>
<person name="Martin S."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Maslen G.L."/>
<person name="Matthews L."/>
<person name="McCann O.T."/>
<person name="McLaren S.J."/>
<person name="McLay K."/>
<person name="McMurray A."/>
<person name="Moore M.J.F."/>
<person name="Mullikin J.C."/>
<person name="Niblett D."/>
<person name="Nickerson T."/>
<person name="Novik K.L."/>
<person name="Oliver K."/>
<person name="Overton-Larty E.K."/>
<person name="Parker A."/>
<person name="Patel R."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Phillimore B.J.C.T."/>
<person name="Phillips S."/>
<person name="Plumb R.W."/>
<person name="Porter K.M."/>
<person name="Ramsey Y."/>
<person name="Ranby S.A."/>
<person name="Rice C.M."/>
<person name="Ross M.T."/>
<person name="Searle S.M."/>
<person name="Sehra H.K."/>
<person name="Sheridan E."/>
<person name="Skuce C.D."/>
<person name="Smith S."/>
<person name="Smith M."/>
<person name="Spraggon L."/>
<person name="Squares S.L."/>
<person name="Steward C.A."/>
<person name="Sycamore N."/>
<person name="Tamlyn-Hall G."/>
<person name="Tester J."/>
<person name="Theaker A.J."/>
<person name="Thomas D.W."/>
<person name="Thorpe A."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Tubby B."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="West A.P."/>
<person name="White S.S."/>
<person name="Whitehead S.L."/>
<person name="Whittaker H."/>
<person name="Wild A."/>
<person name="Willey D.J."/>
<person name="Wilmer T.E."/>
<person name="Wood J.M."/>
<person name="Wray P.W."/>
<person name="Wyatt J.C."/>
<person name="Young L."/>
<person name="Younger R.M."/>
<person name="Bentley D.R."/>
<person name="Coulson A."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Sulston J.E."/>
<person name="Dunham I."/>
<person name="Rogers J."/>
<person name="Beck S."/>
</authorList>
<dbReference type="PubMed" id="14574404"/>
<dbReference type="DOI" id="10.1038/nature02055"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
<source>
<tissue>Prostate</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="1991" name="Science" volume="251" first="1067" last="1071">
<title>Characterization of a dimerization motif in AP-2 and its function in heterologous DNA-binding proteins.</title>
<authorList>
<person name="Williams T."/>
<person name="Tjian R."/>
</authorList>
<dbReference type="PubMed" id="1998122"/>
<dbReference type="DOI" id="10.1126/science.1998122"/>
</citation>
<scope>SUBUNIT</scope>
</reference>
<reference key="8">
<citation type="journal article" date="1991" name="Genes Dev." volume="5" first="670" last="682">
<title>Analysis of the DNA-binding and activation properties of the human transcription factor AP-2.</title>
<authorList>
<person name="Williams T."/>
<person name="Tjian R."/>
</authorList>
<dbReference type="PubMed" id="2010091"/>
<dbReference type="DOI" id="10.1101/gad.5.4.670"/>
</citation>
<scope>DNA-BINDING</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1999" name="FEBS Lett." volume="444" first="27" last="31">
<title>Transcription factor AP-2 activity is modulated by protein kinase A-mediated phosphorylation.</title>
<authorList>
<person name="Garcia M.A."/>
<person name="Campillos M."/>
<person name="Marina A."/>
<person name="Valdivieso F."/>
<person name="Vazquez J."/>
</authorList>
<dbReference type="PubMed" id="10037142"/>
<dbReference type="DOI" id="10.1016/s0014-5793(99)00021-6"/>
</citation>
<scope>PHOSPHORYLATION AT SER-239</scope>
<scope>MUTAGENESIS OF SER-239</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2001" name="Nat. Genet." volume="29" first="469" last="474">
<title>Cardiac malformations, adrenal agenesis, neural crest defects and exencephaly in mice lacking Cited2, a new Tfap2 co-activator.</title>
<authorList>
<person name="Bamforth S.D."/>
<person name="Braganca J."/>
<person name="Eloranta J.J."/>
<person name="Murdoch J.N."/>
<person name="Marques F.I."/>
<person name="Kranc K.R."/>
<person name="Farza H."/>
<person name="Henderson D.J."/>
<person name="Hurst H.C."/>
<person name="Bhattacharya S."/>
</authorList>
<dbReference type="PubMed" id="11694877"/>
<dbReference type="DOI" id="10.1038/ng768"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH CITED2</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="8559" last="8565">
<title>Human CREB-binding protein/p300-interacting transactivator with ED-rich tail (CITED) 4, a new member of the CITED family, functions as a co-activator for transcription factor AP-2.</title>
<authorList>
<person name="Braganca J."/>
<person name="Swingler T."/>
<person name="Marques F.I.R."/>
<person name="Jones T."/>
<person name="Eloranta J.J."/>
<person name="Hurst H.C."/>
<person name="Shioda T."/>
<person name="Bhattacharya S."/>
</authorList>
<dbReference type="PubMed" id="11744733"/>
<dbReference type="DOI" id="10.1074/jbc.m110850200"/>
</citation>
<scope>INTERACTION WITH CITED4</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="30798" last="30804">
<title>Transcription factor AP-2 interacts with the SUMO-conjugating enzyme UBC9 and is sumolated in vivo.</title>
<authorList>
<person name="Eloranta J.J."/>
<person name="Hurst H.C."/>
</authorList>
<dbReference type="PubMed" id="12072434"/>
<dbReference type="DOI" id="10.1074/jbc.m202780200"/>
</citation>
<scope>INTERACTION WITH UBE2I</scope>
<scope>SUMOYLATION AT LYS-10</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="16021" last="16029">
<title>Physical and functional interactions among AP-2 transcription factors, p300/CREB-binding protein, and CITED2.</title>
<authorList>
<person name="Braganca J."/>
<person name="Eloranta J.J."/>
<person name="Bamforth S.D."/>
<person name="Ibbitt J.C."/>
<person name="Hurst H.C."/>
<person name="Bhattacharya S."/>
</authorList>
<dbReference type="PubMed" id="12586840"/>
<dbReference type="DOI" id="10.1074/jbc.m208144200"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>DNA-BINDING</scope>
<scope>INTERACTION WITH CITED2 AND EP300</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="30597" last="30604">
<title>RLIP, an effector of the Ral GTPases, is a platform for Cdk1 to phosphorylate epsin during the switch off of endocytosis in mitosis.</title>
<authorList>
<person name="Rosse C."/>
<person name="L'Hoste S."/>
<person name="Offner N."/>
<person name="Picard A."/>
<person name="Camonis J."/>
</authorList>
<dbReference type="PubMed" id="12775724"/>
<dbReference type="DOI" id="10.1074/jbc.m302191200"/>
</citation>
<scope>INTERACTION WITH RALBP1</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2004" name="Cancer Res." volume="64" first="8256" last="8261">
<title>Physical and functional interactions between the Wwox tumor suppressor protein and the AP-2gamma transcription factor.</title>
<authorList>
<person name="Aqeilan R.I."/>
<person name="Palamarchuk A."/>
<person name="Weigel R.J."/>
<person name="Herrero J.J."/>
<person name="Pekarsky Y."/>
<person name="Croce C.M."/>
</authorList>
<dbReference type="PubMed" id="15548692"/>
<dbReference type="DOI" id="10.1158/0008-5472.can-04-2055"/>
</citation>
<scope>INTERACTION WITH WWOX</scope>
<scope>DOMAIN</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="17">
<citation type="journal article" date="2009" name="J. Cell. Biochem." volume="106" first="285" last="295">
<title>The interaction of KCTD1 with transcription factor AP-2alpha inhibits its transactivation.</title>
<authorList>
<person name="Ding X."/>
<person name="Luo C."/>
<person name="Zhou J."/>
<person name="Zhong Y."/>
<person name="Hu X."/>
<person name="Zhou F."/>
<person name="Ren K."/>
<person name="Gan L."/>
<person name="He A."/>
<person name="Zhu J."/>
<person name="Gao X."/>
<person name="Zhang J."/>
</authorList>
<dbReference type="PubMed" id="19115315"/>
<dbReference type="DOI" id="10.1002/jcb.22002"/>
</citation>
<scope>INTERACTION WITH KCTD1</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="19">
<citation type="journal article" date="2013" name="Proc. Natl. Acad. Sci. U.S.A." volume="110" first="2870" last="2875">
<title>Inhibition of neural crest formation by Kctd15 involves regulation of transcription factor AP-2.</title>
<authorList>
<person name="Zarelli V.E."/>
<person name="Dawid I.B."/>
</authorList>
<dbReference type="PubMed" id="23382213"/>
<dbReference type="DOI" id="10.1073/pnas.1300203110"/>
</citation>
<scope>INTERACTION WITH KCTD15</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
<title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Lyon D."/>
<person name="Young C."/>
<person name="Jensen L.J."/>
<person name="Vertegaal A.C."/>
<person name="Nielsen M.L."/>
</authorList>
<dbReference type="PubMed" id="28112733"/>
<dbReference type="DOI" id="10.1038/nsmb.3366"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-10; LYS-177 AND LYS-184</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2008" name="Am. J. Hum. Genet." volume="82" first="1171" last="1177">
<title>TFAP2A mutations result in branchio-oculo-facial syndrome.</title>
<authorList>
<person name="Milunsky J.M."/>
<person name="Maher T.A."/>
<person name="Zhao G."/>
<person name="Roberts A.E."/>
<person name="Stalker H.J."/>
<person name="Zori R.T."/>
<person name="Burch M.N."/>
<person name="Clemens M."/>
<person name="Mulliken J.B."/>
<person name="Smith R."/>
<person name="Lin A.E."/>
</authorList>
<dbReference type="PubMed" id="18423521"/>
<dbReference type="DOI" id="10.1016/j.ajhg.2008.03.005"/>
</citation>
<scope>VARIANTS BOFS PRO-249; GLY-254; GLY-255 AND GLU-262</scope>
</reference>
<comment type="function">
<text evidence="4 7">Sequence-specific DNA-binding protein that interacts with inducible viral and cellular enhancer elements to regulate transcription of selected genes. AP-2 factors bind to the consensus sequence 5'-GCCNNNGGC-3' and activate genes involved in a large spectrum of important biological functions including proper eye, face, body wall, limb and neural tube development. They also suppress a number of genes including MCAM/MUC18, C/EBP alpha and MYC. AP-2-alpha is the only AP-2 protein required for early morphogenesis of the lens vesicle. Together with the CITED2 coactivator, stimulates the PITX2 P1 promoter transcription activation. Associates with chromatin to the PITX2 P1 promoter region.</text>
</comment>
<comment type="subunit">
<text evidence="4 5 6 7 8 9 11 12 13">Binds DNA as a dimer. Can form homodimers or heterodimers with other AP-2 family members. Interacts with WWOX. Interacts with CITED4. Interacts with UBE2I. Interacts with RALBP1 in a complex also containing EPN1 and NUMB during interphase and mitosis. Interacts with KCTD1; this interaction represses transcription activation. Interacts (via C-terminus) with CITED2 (via C-terminus); the interaction stimulates TFAP2A-transcriptional activation. Interacts (via N-terminus) with EP300 (via N-terminus); the interaction requires CITED2. Interacts with KCTD15; this interaction inhibits TFAP2A transcriptional activation.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-347351">
<id>P05549</id>
</interactant>
<interactant intactId="EBI-447295">
<id>Q09472</id>
<label>EP300</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-347351">
<id>P05549</id>
</interactant>
<interactant intactId="EBI-10194609">
<id>Q9H4Y5</id>
<label>GSTO2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-347351">
<id>P05549</id>
</interactant>
<interactant intactId="EBI-751711">
<id>P61244</id>
<label>MAX</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-347351">
<id>P05549</id>
</interactant>
<interactant intactId="EBI-2340269">
<id>Q13064</id>
<label>MKRN3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-347351">
<id>P05549</id>
</interactant>
<interactant intactId="EBI-78579">
<id>P06748</id>
<label>NPM1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-347351">
<id>P05549</id>
</interactant>
<interactant intactId="EBI-80168">
<id>P63279</id>
<label>UBE2I</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-12194905">
<id>P05549-5</id>
</interactant>
<interactant intactId="EBI-10194609">
<id>Q9H4Y5</id>
<label>GSTO2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-12194905">
<id>P05549-5</id>
</interactant>
<interactant intactId="EBI-6509505">
<id>Q0VD86</id>
<label>INCA1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="7">Nucleus</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P05549-1</id>
<name>1</name>
<name>AP-2A</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P05549-5</id>
<name>2</name>
<sequence type="described" ref="VSP_043268"/>
</isoform>
<isoform>
<id>P05549-2</id>
<name>4</name>
<name>AP-2B</name>
<sequence type="described" ref="VSP_006401"/>
</isoform>
<isoform>
<id>P05549-6</id>
<name>5</name>
<sequence type="described" ref="VSP_047050"/>
</isoform>
<text>Experimental confirmation may be lacking for some isoforms.</text>
</comment>
<comment type="domain">
<text evidence="2">The PPxY motif mediates interaction with WWOX.</text>
</comment>
<comment type="PTM">
<text evidence="17">Sumoylated on Lys-10; which inhibits transcriptional activity.</text>
</comment>
<comment type="disease" evidence="10">
<disease id="DI-01294">
<name>Branchiooculofacial syndrome</name>
<acronym>BOFS</acronym>
<description>A syndrome characterized by growth retardation, bilateral branchial sinus defects with hemangiomatous, scarred skin, cleft lip with or without cleft palate, pseudocleft of the upper lip, nasolacrimal duct obstruction, low set ears with posterior rotation, a malformed, asymmetrical nose with a broad bridge and flattened tip, conductive or sensorineural deafness, ocular and renal anomalies.</description>
<dbReference type="MIM" id="113620"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="miscellaneous">
<molecule>Isoform 4</molecule>
<text evidence="16">May be an aberrantly processed form with no significant distribution in vivo.</text>
</comment>
<comment type="similarity">
<text evidence="16">Belongs to the AP-2 family.</text>
</comment>
<comment type="online information" name="Wikipedia">
<link uri="https://en.wikipedia.org/wiki/Activating_protein_2"/>
<text>Activating protein 2 entry</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/TFAP2AID42526ch6p24.html"/>
</comment>
<dbReference type="EMBL" id="M36711">
<property type="protein sequence ID" value="AAA35539.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M61156">
<property type="protein sequence ID" value="AAA02487.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X52611">
<property type="protein sequence ID" value="CAA36842.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X77343">
<property type="protein sequence ID" value="CAB59735.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL138885">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471087">
<property type="protein sequence ID" value="EAW55249.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC017754">
<property type="protein sequence ID" value="AAH17754.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS34337.1">
<molecule id="P05549-5"/>
</dbReference>
<dbReference type="CCDS" id="CCDS43422.1">
<molecule id="P05549-6"/>
</dbReference>
<dbReference type="PIR" id="A31752">
<property type="entry name" value="A31752"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001027451.1">
<molecule id="P05549-5"/>
<property type="nucleotide sequence ID" value="NM_001032280.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001035890.1">
<molecule id="P05549-6"/>
<property type="nucleotide sequence ID" value="NM_001042425.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_003211.1">
<property type="nucleotide sequence ID" value="NM_003220.2"/>
</dbReference>
<dbReference type="SMR" id="P05549"/>
<dbReference type="BioGRID" id="112878">
<property type="interactions" value="75"/>
</dbReference>
<dbReference type="CORUM" id="P05549"/>
<dbReference type="IntAct" id="P05549">
<property type="interactions" value="92"/>
</dbReference>
<dbReference type="MINT" id="P05549"/>
<dbReference type="STRING" id="9606.ENSP00000368924"/>
<dbReference type="iPTMnet" id="P05549"/>
<dbReference type="PhosphoSitePlus" id="P05549"/>
<dbReference type="BioMuta" id="TFAP2A"/>
<dbReference type="DMDM" id="135302"/>
<dbReference type="EPD" id="P05549"/>
<dbReference type="jPOST" id="P05549"/>
<dbReference type="MassIVE" id="P05549"/>
<dbReference type="PaxDb" id="P05549"/>
<dbReference type="PeptideAtlas" id="P05549"/>
<dbReference type="PRIDE" id="P05549"/>
<dbReference type="ProteomicsDB" id="51847">
<molecule id="P05549-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="51848">
<molecule id="P05549-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="51849">
<molecule id="P05549-5"/>
</dbReference>
<dbReference type="ProteomicsDB" id="64874"/>
<dbReference type="Antibodypedia" id="3770">
<property type="antibodies" value="535 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="7020"/>
<dbReference type="Ensembl" id="ENST00000319516">
<molecule id="P05549-6"/>
<property type="protein sequence ID" value="ENSP00000316516"/>
<property type="gene ID" value="ENSG00000137203"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000379608">
<molecule id="P05549-5"/>
<property type="protein sequence ID" value="ENSP00000368928"/>
<property type="gene ID" value="ENSG00000137203"/>
</dbReference>
<dbReference type="GeneID" id="7020"/>
<dbReference type="KEGG" id="hsa:7020"/>
<dbReference type="UCSC" id="uc003myq.4">
<molecule id="P05549-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="7020"/>
<dbReference type="DisGeNET" id="7020"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000137203.10"/>
<dbReference type="GeneCards" id="TFAP2A"/>
<dbReference type="GeneReviews" id="TFAP2A"/>
<dbReference type="HGNC" id="HGNC:11742">
<property type="gene designation" value="TFAP2A"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000137203">
<property type="expression patterns" value="Tissue enhanced (placenta, retina)"/>
</dbReference>
<dbReference type="MalaCards" id="TFAP2A"/>
<dbReference type="MIM" id="107580">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="113620">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P05549"/>
<dbReference type="OpenTargets" id="ENSG00000137203"/>
<dbReference type="Orphanet" id="1297">
<property type="disease" value="Branchio-oculo-facial syndrome"/>
</dbReference>
<dbReference type="PharmGKB" id="PA36459"/>
<dbReference type="eggNOG" id="KOG3811">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00950000182848"/>
<dbReference type="HOGENOM" id="CLU_035175_4_1_1"/>
<dbReference type="InParanoid" id="P05549"/>
<dbReference type="KO" id="K09176"/>
<dbReference type="OrthoDB" id="641707at2759"/>
<dbReference type="PhylomeDB" id="P05549"/>
<dbReference type="TreeFam" id="TF313718"/>
<dbReference type="PathwayCommons" id="P05549"/>
<dbReference type="Reactome" id="R-HSA-3232118">
<molecule id="P05549-1"/>
<property type="pathway name" value="SUMOylation of transcription factors"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8864260">
<property type="pathway name" value="Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8866904">
<property type="pathway name" value="Negative regulation of activity of TFAP2 (AP-2) family transcription factors"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8866906">
<property type="pathway name" value="TFAP2 (AP-2) family regulates transcription of other transcription factors"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8866907">
<property type="pathway name" value="Activation of the TFAP2 (AP-2) family of transcription factors"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8866910">
<property type="pathway name" value="TFAP2 (AP-2) family regulates transcription of growth factors and their receptors"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8866911">
<property type="pathway name" value="TFAP2 (AP-2) family regulates transcription of cell cycle factors"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8869496">
<property type="pathway name" value="TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation"/>
</dbReference>
<dbReference type="SignaLink" id="P05549"/>
<dbReference type="SIGNOR" id="P05549"/>
<dbReference type="BioGRID-ORCS" id="7020">
<property type="hits" value="27 hits in 898 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="TFAP2A">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="TFAP2A"/>
<dbReference type="GenomeRNAi" id="7020"/>
<dbReference type="Pharos" id="P05549">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:P05549"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 6"/>
</dbReference>
<dbReference type="RNAct" id="P05549">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000137203">
<property type="expression patterns" value="Expressed in placenta and 176 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P05549">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P05549">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0000790">
<property type="term" value="C:nuclear chromatin"/>
<property type="evidence" value="ECO:0000247"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003682">
<property type="term" value="F:chromatin binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003677">
<property type="term" value="F:DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001228">
<property type="term" value="F:DNA-binding transcription activator activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000981">
<property type="term" value="F:DNA-binding transcription factor activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001227">
<property type="term" value="F:DNA-binding transcription repressor activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000978">
<property type="term" value="F:RNA polymerase II cis-regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000977">
<property type="term" value="F:RNA polymerase II transcription regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0043565">
<property type="term" value="F:sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1990837">
<property type="term" value="F:sequence-specific double-stranded DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0000976">
<property type="term" value="F:transcription regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048856">
<property type="term" value="P:anatomical structure development"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0060349">
<property type="term" value="P:bone morphogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071281">
<property type="term" value="P:cellular response to iron ion"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048701">
<property type="term" value="P:embryonic cranial skeleton morphogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035115">
<property type="term" value="P:embryonic forelimb morphogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0061029">
<property type="term" value="P:eyelid development in camera-type eye"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042472">
<property type="term" value="P:inner ear morphogenesis"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001822">
<property type="term" value="P:kidney development"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043066">
<property type="term" value="P:negative regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008285">
<property type="term" value="P:negative regulation of cell population proliferation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000378">
<property type="term" value="P:negative regulation of reactive oxygen species metabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010944">
<property type="term" value="P:negative regulation of transcription by competitive promoter binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000122">
<property type="term" value="P:negative regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045892">
<property type="term" value="P:negative regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0021623">
<property type="term" value="P:oculomotor nerve formation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003409">
<property type="term" value="P:optic cup structural organization"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003404">
<property type="term" value="P:optic vesicle morphogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030501">
<property type="term" value="P:positive regulation of bone mineralization"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010628">
<property type="term" value="P:positive regulation of gene expression"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043525">
<property type="term" value="P:positive regulation of neuron apoptotic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070172">
<property type="term" value="P:positive regulation of tooth mineralization"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045595">
<property type="term" value="P:regulation of cell differentiation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042127">
<property type="term" value="P:regulation of cell population proliferation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0006357">
<property type="term" value="P:regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0010842">
<property type="term" value="P:retina layer formation"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060021">
<property type="term" value="P:roof of mouth development"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007605">
<property type="term" value="P:sensory perception of sound"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0021559">
<property type="term" value="P:trigeminal nerve development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="InterPro" id="IPR004979">
<property type="entry name" value="TF_AP2"/>
</dbReference>
<dbReference type="InterPro" id="IPR008121">
<property type="entry name" value="TF_AP2_alpha_N"/>
</dbReference>
<dbReference type="InterPro" id="IPR013854">
<property type="entry name" value="TF_AP2_C"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR10812">
<property type="entry name" value="PTHR10812"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF03299">
<property type="entry name" value="TF_AP-2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR01749">
<property type="entry name" value="AP2ATNSCPFCT"/>
</dbReference>
<dbReference type="PRINTS" id="PR01748">
<property type="entry name" value="AP2TNSCPFCT"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0010">Activator</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Transcription factor AP-2-alpha" id="PRO_0000184796">
<location>
<begin position="1"/>
<end position="437"/>
</location>
</feature>
<feature type="region of interest" description="H-S-H (helix-span-helix), dimerization">
<location>
<begin position="280"/>
<end position="410"/>
</location>
</feature>
<feature type="short sequence motif" description="PPxY motif">
<location>
<begin position="57"/>
<end position="62"/>
</location>
</feature>
<feature type="compositionally biased region" description="Gln/Pro-rich (transactivation domain)">
<location>
<begin position="29"/>
<end position="117"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by PKA" evidence="3">
<location>
<position position="239"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate" evidence="6">
<location>
<position position="10"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="1">
<location>
<position position="10"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="1">
<location>
<position position="177"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="1">
<location>
<position position="184"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_043268" evidence="14">
<original>MLWKLTDNIKYEDCE</original>
<variation>MLVHSFSAM</variation>
<location>
<begin position="1"/>
<end position="15"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 5." id="VSP_047050" evidence="16">
<original>MLWKLTDNIKYEDCE</original>
<variation>MSILAKMGDWQ</variation>
<location>
<begin position="1"/>
<end position="15"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_006401" evidence="15">
<original>EAVHLARDFGYVCETEFPAKAVAEFLNRQHSDPNEQVTRKNMLLATKQICKEFTDLLAQDRSPLGNSRPNPILEPGIQSCLTHFNLISHGFGSPAVCAAVTALQNYLTEALKAMDKMYLSNNPNSHTDNNAKSSDKEEKHRK</original>
<variation>KRIHLLTRRNFLLGKWIIFSGQMFGRILCQLGSFIFAENIARCEWNYFMAKRNICMYSYTSILLPSFPLP</variation>
<location>
<begin position="296"/>
<end position="437"/>
</location>
</feature>
<feature type="sequence variant" description="In BOFS." id="VAR_045838" evidence="10">
<original>L</original>
<variation>P</variation>
<location>
<position position="249"/>
</location>
</feature>
<feature type="sequence variant" description="In BOFS; dbSNP:rs151344528." id="VAR_045839" evidence="10">
<original>R</original>
<variation>G</variation>
<location>
<position position="254"/>
</location>
</feature>
<feature type="sequence variant" description="In BOFS; dbSNP:rs121909574." id="VAR_045840" evidence="10">
<original>R</original>
<variation>G</variation>
<location>
<position position="255"/>
</location>
</feature>
<feature type="sequence variant" description="In BOFS; dbSNP:rs121909575." id="VAR_045841" evidence="10">
<original>G</original>
<variation>E</variation>
<location>
<position position="262"/>
</location>
</feature>
<feature type="mutagenesis site" description="No phosphorylation." evidence="3">
<original>S</original>
<variation>A</variation>
<location>
<position position="239"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="28112733"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000250"/>
<evidence key="3" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10037142"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11694877"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11744733"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12072434"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12586840"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12775724"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15548692"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18423521"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19115315"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1998122"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23382213"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="8321221"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000305"/>
<evidence key="17" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="12072434"/>
</source>
</evidence>
<sequence length="437" mass="48062" checksum="FB8FA33C3AEED71F" modified="1989-07-01" version="1">MLWKLTDNIKYEDCEDRHDGTSNGTARLPQLGTVGQSPYTSAPPLSHTPNADFQPPYFPPPYQPIYPQSQDPYSHVNDPYSLNPLHAQPQPQHPGWPGQRQSQESGLLHTHRGLPHQLSGLDPRRDYRRHEDLLHGPHALSSGLGDLSIHSLPHAIEEVPHVEDPGINIPDQTVIKKGPVSLSKSNSNAVSAIPINKDNLFGGVVNPNEVFCSVPGRLSLLSSTSKYKVTVAEVQRRLSPPECLNASLLGGVLRRAKSKNGGRSLREKLDKIGLNLPAGRRKAANVTLLTSLVEGEAVHLARDFGYVCETEFPAKAVAEFLNRQHSDPNEQVTRKNMLLATKQICKEFTDLLAQDRSPLGNSRPNPILEPGIQSCLTHFNLISHGFGSPAVCAAVTALQNYLTEALKAMDKMYLSNNPNSHTDNNAKSSDKEEKHRK</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

